Open access
Aug 2026
Impact of CYP2C19 loss-of-function variants on outcomes in atrial fibrillation patients undergoing percutaneous coronary intervention: rationale and study design of the WOEST-3 genetic substudy
The rationale and design of a genetic substudy aimed at clarifying the prognostic relevance of CYP2C19 genotype in AF patients undergoing PCI and informing the design of future genotype-guided antithrombotic trials are described.
S. Chiusolo, A. Verburg, C. Morizzo et al.
· Bleeding Thrombosis and Vasc... · 0 citations